CRISPR-based molecule-regulatory expression platform for specific immunotherapy of cancer
IntroductionCancer is still a major challenge of human health. The abnormality of intracellular cancer-related signal pathways is an important mechanism for the occurrence of cancer.MethodsWe used a molecular-senor to act on the endogenous signal molecules within the cell to redirect the abnormal si...
Saved in:
| Main Authors: | Tianying Zhan, Lu Tong, Linlin Wang, Jun Dong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-10-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1469319/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer
by: Chujin Ye, et al.
Published: (2025-01-01) -
Prognostic value of LncRNA DLGAP1-AS2 in bladder cancer and its regulatory effect on tumor progression
by: Yuhui Zhao, et al.
Published: (2025-08-01) -
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies
by: Samira Anvari, et al.
Published: (2024-12-01) -
Prognosis and immune landscape of bladder cancer can be predicted using a novel miRNA signature associated with cuproptosis
by: Zhilei Zhang, et al.
Published: (2024-11-01) -
Recent progress in miRNA biogenesis and decay
by: Xavier Bofill-De Ros, et al.
Published: (2024-12-01)